{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:52:37Z","timestamp":1767156757341},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s10620-006-9336-5","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T13:58:15Z","timestamp":1150207095000},"page":"968-975","source":"Crossref","is-referenced-by-count":60,"title":["Thiopurine Methyltransferase Deficiency and Azathioprine Intolerance in Autoimmune Hepatitis"],"prefix":"10.1007","volume":"51","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herschel A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,6,14]]},"reference":[{"key":"9336_CR1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 36:479\u2013497, 2002","journal-title":"Hepatology"},{"key":"9336_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2002-35706","volume":"22","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ: Treatment of autoimmune hepatitis. Semin Liver Dis 22:365\u2013377, 2002","journal-title":"Semin Liver Dis"},{"key":"9336_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archinte.1981.00340020085022","volume":"141","author":"BR Bacon","year":"1981","unstructured":"Bacon BR, Treuhaft WH, Goodman AM: Azathioprine-induced pancytopenia. Occurrence in two patients with connective tissue diseases. Arch Intern Med 141:223\u2013226, 1981","journal-title":"Arch Intern Med"},{"key":"9336_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.38.2.258","volume":"38","author":"R Hohlfeld","year":"1988","unstructured":"Hohlfeld R, Michels M, Heininger K, Besinger V, Toyka KV: Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38:258\u2013261, 1988","journal-title":"Neurology"},{"key":"9336_CR5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.47.6.503","volume":"47","author":"MEC Jeurissen","year":"1988","unstructured":"Jeurissen MEC, Boerbooms AMTH, Van De Putte LBA: Pancytopenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 47:503\u2013505, 1988","journal-title":"Ann Rheum Dis"},{"key":"9336_CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(86)92291-9","volume":"i","author":"JL Maddocks","year":"1986","unstructured":"Maddocks JL, Lennard L, Amess J, Amor R, Meyrick Thomas R: Azathioprine and severe bone marrow depression. Lancet i:156, 1986","journal-title":"Lancet"},{"key":"9336_CR7","first-page":"351","volume":"23","author":"Z Ben Ari","year":"1995","unstructured":"Ben Ari Z, Mehta A, Lennard L, Burroughs AK: Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. J Hepatol 23:351\u2013354, 1995","journal-title":"J Hepatol"},{"key":"9336_CR8","first-page":"360","volume":"55","author":"AJ Czaja","year":"1980","unstructured":"Czaja AJ, Wolf AM, Baggenstoss AH: Clinical assessment of cirrhosis in severe chronic active liver disease (CALD): Specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 55:360\u2013364, 1980","journal-title":"Mayo Clin Proc"},{"key":"9336_CR9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1089-3261(02)00028-4","volume":"6","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ: Treatment strategies in autoimmune hepatitis. Clin Liver Dis 6:799-824, 2002","journal-title":"Clin Liver Dis"},{"key":"9336_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","volume":"333","author":"PJ Johnson","year":"1995","unstructured":"Johnson PJ, McFarlane IG, Williams R: Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333:958\u2013963, 1995","journal-title":"N Engl J Med"},{"key":"9336_CR11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","volume":"37","author":"PG Langley","year":"2002","unstructured":"Langley PG, Underhill J, Tredger JM, Norris S, McFarlane IG: Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol 37:441\u2013447, 2002","journal-title":"J Hepatol"},{"key":"9336_CR12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","volume":"122","author":"MC Dubinsky","year":"2002","unstructured":"Dubinsky MC, Yang H, Hassard PV, et al.: 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 122:904\u2013915, 2002","journal-title":"Gastroenterology"},{"key":"9336_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1542-3565(04)00127-2","volume":"2","author":"C Cuffari","year":"2004","unstructured":"Cuffari C, Dassopoulis T, Turnbough L, Thompson RE, Bayless TM: Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2:410\u2013417, 2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9336_CR14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-129-9-199811010-00007","volume":"129","author":"AJ Black","year":"1998","unstructured":"Black AJ, McLeod HL, Capell HA, et al.: Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 129:716\u2013718, 1998","journal-title":"Ann Intern Med"},{"key":"9336_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.1997.t01-1-00607.x","volume":"44","author":"L Lennard","year":"1997","unstructured":"Lennard L, Welch JC, Lilleyman JS: Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Br J Clin Pharmacol 44:455\u2013461, 1997","journal-title":"Br J Clin Pharmacol"},{"key":"9336_CR16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.leu.2401723","volume":"14","author":"HL McLeod","year":"2000","unstructured":"McLeod HL, Krynetski EY, Relling MV, Evans WE: Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567\u2013572, 2000","journal-title":"Leukemia"},{"key":"9336_CR17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1053\/j.gastro.2004.09.061","volume":"127","author":"GR Lichtenstein","year":"2004","unstructured":"Lichtenstein GR: Use of laboratory testing to guide 6-mercaptopurine\/azathioprine therapy. Gastroenterology 127:1558\u20131564, 2004","journal-title":"Gastroenterology"},{"key":"9336_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-200209000-00008","volume":"35","author":"M Regueiro","year":"2002","unstructured":"Regueiro M, Mardini H: Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn\u2019s disease. J Clin Gastroenterol 35:240\u2013244, 2002","journal-title":"J Clin Gastroenterol"},{"key":"9336_CR19","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","volume":"93","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Boyett JM, Pui C-H, Evans WE: Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93:2817\u20132823, 1999","journal-title":"Blood"},{"key":"9336_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","volume":"35","author":"MA Heneghan","year":"2002","unstructured":"Heneghan MA, McFarlane IG: Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35:7\u201313, 2002","journal-title":"Hepatology"},{"key":"9336_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/art.1780160113","volume":"16","author":"JR Bertino","year":"1973","unstructured":"Bertino JR: Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man. Arthritis Rheum 16:79\u201383, 1973","journal-title":"Arthritis Rheum"},{"key":"9336_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","volume":"43","author":"L Lennard","year":"1992","unstructured":"Lennard L: The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 43:329\u201339, 1992","journal-title":"Eur J Clin Pharmacol"},{"key":"9336_CR23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/j.1552-4604.1990.tb03606.x","volume":"30","author":"GLC Chan","year":"1990","unstructured":"Chan GLC, Erdmann GR, Gruber SA, Matas AJ, Canafax DM: Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 30:358\u2013363, 1990","journal-title":"J Clin Pharmacol"},{"key":"9336_CR24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00007691-200404000-00024","volume":"26","author":"VW Armstrong","year":"2004","unstructured":"Armstrong VW, Shipkova M, von Ahsen N, Oellerich M: Analytic aspects of monitoring therapy with thiopurine medications. Ther Drug Monit 26:220\u2013226, 2004","journal-title":"Ther Drug Monit"},{"key":"9336_CR25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","volume":"2","author":"C Szumlanski","year":"1992","unstructured":"Szumlanski C, Honchel R, Scott M, Weinshilboum RM: Human liver thiopurine methyltransferase pharmacogenetics: Biochemical properties, liver-erythrocyte correlation and presence of isoenzymes. Pharmacogenetics 2:148\u2013159, 1992","journal-title":"Pharmacogenetics"},{"key":"9336_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","volume":"6","author":"EY Krynetski","year":"1996","unstructured":"Krynetski EY, Tai HL, Yates CR, et al.: Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 6:279\u2013290, 1996","journal-title":"Pharmacogenetics"},{"key":"9336_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","volume":"62","author":"D Otterness","year":"1997","unstructured":"Otterness D, Szumlanski C, Lennard L, et al.: Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62:60\u201373, 1997","journal-title":"Clin Pharmacol Ther"},{"key":"9336_CR28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","volume":"126","author":"CR Yates","year":"1997","unstructured":"Yates CR, Krynetski EY, Loennechen T, et al.: Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126:608\u2013614, 1997","journal-title":"Ann Intern Med"},{"key":"9336_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<246::AID-HUMU5>3.0.CO;2-#","volume":"15","author":"S Alves","year":"2000","unstructured":"Alves S, Prata MJ, Ferreira F, Amorim A: Screening of thiopurine methyl s-transferase mutations by horizontal conformation-sensitive gel electrophoresis. Hum Mutat 15:246\u2013253, 2000","journal-title":"Hum Mutat"},{"key":"9336_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1994.4","volume":"55","author":"HL McLeod","year":"1994","unstructured":"McLeod HL, Lin JS, Scott EP, Pui C-H, Evans WE: Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55:15\u201320, 1994","journal-title":"Clin Pharmacol Ther"},{"key":"9336_CR31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al.: International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938, 1999","journal-title":"J Hepatol"},{"key":"9336_CR32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0009-8981(78)90311-X","volume":"85","author":"RM Weinshilboum","year":"1978","unstructured":"Weinshilboum RM, Raymond FA, Pazmino PA: Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clinica Chimica Acta 85:323\u2013333, 1978","journal-title":"Clinica Chimica Acta"},{"key":"9336_CR33","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL: Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Human Genet 32:651\u2013662, 1980","journal-title":"Am J Human Genet"},{"key":"9336_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0163-7258(89)90048-X","volume":"43","author":"R Weinshilboum","year":"1989","unstructured":"Weinshilboum R: Methyltransferase pharmacogenetics. Pharmacol Ther 43:77\u201390, 1989","journal-title":"Pharmacol Ther"},{"key":"9336_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0025-7753(03)73996-7","volume":"121","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Gonzalez-Guijarro L, Cara C, Pajares JM, Moreno-Otero R: Thiopurine methyltransferase activity in patients with autoimmune hepatitis. Med Clin (Barc) 121:481\u2013484, 2003","journal-title":"Med Clin (Barc)"},{"key":"9336_CR36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.20235","volume":"39","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Carpenter HA: Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39:1631\u20131638, 2004","journal-title":"Hepatology"},{"key":"9336_CR37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jhep.2004.01.009","volume":"40","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Carpenter HA: Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40:644\u2013650, 2004","journal-title":"J Hepatol"},{"key":"9336_CR38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","volume":"125","author":"de la Spire-Vayron","year":"1998","unstructured":"Spire-Vayron de la Moureyre C, Debuysere J, Masain B, et al.: Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 125:879\u2013887, 1998","journal-title":"Br J Pharmacol"},{"key":"9336_CR39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-199912000-00012","volume":"9","author":"HL McLeod","year":"1999","unstructured":"McLeod HL, Pritchard SC, Githang\u2019a J, et al.: Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence of allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 9:773\u2013776, 1999","journal-title":"Pharmacogenetics"},{"key":"9336_CR40","first-page":"601","volume":"29","author":"R Weinshilboum","year":"2001","unstructured":"Weinshilboum R: Thiopurine pharmacogenetics: Clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos 29:601\u2013605, 2001","journal-title":"Drug Metab Dispos"},{"key":"9336_CR41","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","volume":"85","author":"HL McLeod","year":"1995","unstructured":"McLeod HL, Relling MV, Liu Q, Pui C-H, Evans WE: Polymorphic thiopurine methyl transferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85:1897\u20131902, 1995","journal-title":"Blood"},{"key":"9336_CR42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/gut.52.1.140","volume":"52","author":"BA Kaskas","year":"2003","unstructured":"Kaskas BA, Louis E, Hindorf U, et al.: Safe treatment of thiopurine S-methyltransferase deficient Crohn\u2019s disease patients with azathioprine. Gut 52:140\u2013142, 2003","journal-title":"Gut"},{"key":"9336_CR43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.48.5.591","volume":"48","author":"WJ Sandborn","year":"2001","unstructured":"Sandborn WJ: Rational dosing of azathioprine and 6-mercaptopurine. Gut 48:591\u2013592, 2001","journal-title":"Gut"},{"key":"9336_CR44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gut.39.3.401","volume":"39","author":"C Cuffari","year":"1996","unstructured":"Cuffari C, Theoret Y, Latour S, Seidman G: 6-mercaptopurine metabolism in Crohn\u2019s disease: Correlation with efficacy and toxicity. Gut 39:401\u2013406, 1996","journal-title":"Gut"},{"key":"9336_CR45","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky MC, Lamothe S, Yang HY, et al.: Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118:705\u2013713, 2000","journal-title":"Gastroenterology"},{"key":"9336_CR46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.49.5.665","volume":"40","author":"PW Lowry","year":"2001","unstructured":"Lowry PW, Franklin CL, Weaver AL, et al.: Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 40:665\u2013670, 2001","journal-title":"Gut"},{"key":"9336_CR47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00007691-200206000-00005","volume":"24","author":"B Pettersson","year":"2002","unstructured":"Pettersson B, Almer S, Albertioni F, Soderhall S, Peterson C: Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate. Ther Drug Monit 24:351\u2013358, 2002","journal-title":"Ther Drug Monit"},{"key":"9336_CR48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/00365520310005082","volume":"38","author":"LO Reuter","year":"2003","unstructured":"Reuter LO, Sonne J, Larsen NE, et al.: Pharmacological monitoring of azathioprine therapy. Scand J Gastroenterol 38:972\u2013979, 2003","journal-title":"Scand J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9336-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-006-9336-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9336-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T12:28:20Z","timestamp":1586953700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-006-9336-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["9336"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9336-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}